JUPITER NEUROSCIENCES, INC. Compensation Expense, Excluding Cost of Good and Service Sold
JUPITER NEUROSCIENCES, INC. (JUNS) reported Compensation Expense, Excluding Cost of Good and Service Sold of $945.24 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold · last filed 2026-08-14
- JUPITER NEUROSCIENCES, INC. compensation expense, excluding cost of good and service sold for the quarter ending 2026-06-30 was $491.00K.
- JUPITER NEUROSCIENCES, INC. compensation expense, excluding cost of good and service sold for the quarter ending 2026-03-31 was $454.24K.
| Period end | Compensation Expense, Excluding Cost of Good and Service Sold 3 month | Compensation Expense, Excluding Cost of Good and Service Sold 6 month |
|---|---|---|
| 2026-06-30 | $491.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $945.24K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $454.24K 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |